Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S

Various vaccines were developed to reduce the spread of the Severe Acute Respiratory Syndrome Cov-2 (SARS-CoV-2) virus. Quickly after the start of vaccination, reports emerged that anti-SARS-CoV-2 vaccines, including ChAdOx1-S, could be associated with an increased risk of thrombosis. We investigate...

Full description

Bibliographic Details
Main Authors: Bas de Laat, Hendrik Stragier, Romy de Laat-Kremers, Marisa Ninivaggi, Dieter Mesotten, Steven Thiessen, Kristien Van Pelt, Mark Roest, Joris Penders, Pascal Vanelderen, Dana Huskens, Raf De Jongh, Margot Vander Laenen, Tom Fivez, Hugo ten Cate, Rene Heylen, Line Heylen, Deborah Steensels
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ChAdOx1-S
COVID-19
thrombin generation
vaccination
hemostasis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.966028/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.966028/full

Similar Items